Abstract

Recent studies have shown that as the average life expectancy increases, more people will suffer a stroke in their lives, diminishing their quality of life. Secondary stroke prevention involves reducing the cardiovascular risk factors and administering medication for preventive purposes, where statins play an important role. The purpose of this study is to highlight the correlations of statins dosage with cardiovascular risk factors (atheromatosis, uric acid value, obesity, etc), in stroke patients receiving hypolipidemic treatment with statins.

Highlights

  • Recent studies have shown that as the average life expectancy increases, more people will suffer a stroke in their lives, diminishing their quality of life

  • Experimental part The purpose of this study is to highlight the correlations between the value of statins and other cardiovascular risk factors in patients with stroke receiving hypolipidemic therapy with statins as secondary prevention

  • The international guidelines in place for ischemic stroke mention the need for statins to be used as secondary prevention [13]

Read more

Summary

Effects of Statin Therapy in Patients with Stroke and Atheromatosis

CRISTINA GROSU1, ALEXANDRA MASTALERU2*, OTILIA NITA3*, ROXANA GABRIELA COBZARU4, CARMEN VALERICA RAPA4, MARIA MAGDALENA LEON-CONSTANTIN2* , ELENA COJOCARU5 1Grigore T. University of Medicine and Pharmacy, Faculty of Medicine, IIIrd Medical Department, Discipline of Neurology; 16 Universitatii Str., 700115, Iasi, Romania 2Grigore T. University of Medicine and Pharmacy, Faculty of Medicine, IInd Medical Department, Discipline of Diabetes, Nutrition and Metabolic diseases; 16 Universitatii Str., 700115, Iasi, Romania 4Grigore T. The purpose of this study is to highlight the correlations of statins dosage with cardiovascular risk factors (atheromatosis, uric acid value, obesity, etc), in stroke patients receiving hypolipidemic treatment with statins. Experimental part The purpose of this study is to highlight the correlations between the value of statins and other cardiovascular risk factors (diabetes, atheromatosis, uric acid value) in patients with stroke receiving hypolipidemic therapy with statins as secondary prevention. Most patients had a history of elevated blood pressure (82.8% vs.17.2%) and presented with atheroma plaques in the carotid artery at the Doppler examination (53.4% vs.46.5%). 36.2% of the

THE STUDY GROUP
Results and discussions
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call